Jelikalite

JelikaLite is a pioneering medical technology startup focused on pediatric neurological health, specifically targeting autism spectrum disorder (ASD). Autism is a lifelong developmental disorder that affects communication, behavior, and social interaction. The company is developing an innovative solution called Cognilum, which aims to permanently reduce autism symptoms in children.

Cognilum is a therapeutic wearable device that uses LED lights and sensors to provide non-invasive brain stimulation. This device is designed to be used at home, offering families the flexibility, privacy, and convenience of administering therapy without the need for a therapist's physical presence. The device aims to improve speech, reduce anxiety, and enhance responsiveness in children with autism.

JelikaLite operates in the medical technology market, specifically within the niche of pediatric neurological health. The company serves families with children on the autism spectrum, providing them with a novel, home-based therapy option.

The business model of JelikaLite revolves around the development, clinical testing, and commercialization of Cognilum. The company generates revenue through the sale of its therapeutic devices. Additionally, JelikaLite is in the process of applying for the breakthrough device designation, which could expedite the device's availability in the market.

JelikaLite has already completed Phase 1 clinical trials for safety and efficacy, with promising results. The company has also been awarded a National Science Foundation SBIR Phase 1 grant, which supports its ongoing research and development efforts.

In summary, JelikaLite is a medical technology company dedicated to improving the lives of children with autism through innovative, non-invasive therapies. By focusing on home-based solutions, the company aims to provide accessible and effective treatment options for families.

Keywords: Autism, Pediatric, Neurological, Health, Wearable, LED, Non-invasive, Therapy, Home-based, Cognilum.